Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.075 USD | -1.19% | -2.48% | +5.82% |
05-20 | Barclays Adjusts Price Target on GoodRx to $10 From $9, Maintains Overweight Rating | MT |
05-17 | UBS Adjusts Price Target on GoodRx Holdings to $9 From $8, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.82% | 2.69B | |
+30.93% | 456B | |
+32.35% | 280B | |
+5.91% | 134B | |
+29.89% | 94.31B | |
+5.43% | 91.48B | |
+59.57% | 60.48B | |
+13.86% | 46.13B | |
+25.91% | 37.31B | |
-0.15% | 35.48B |
- Stock Market
- Equities
- GDRX Stock
- News GoodRx Holdings, Inc.
- Goldman Sachs Raises Price Target on GoodRx to $6.50 From $6, Maintains Neutral Rating